ARCHIVES

Risk-Benefit Analysis Advised Prior To Hormone Therapy

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Preparing RFA for Genetics Network; Patients Want Gene-Environment Studies

August 9, 1996

NCAB Delays Decision On Organ Site Program Until May Meeting

February 12, 1982

NCI To Require Reports On Adverse Drug Reactions From Trials

June 10, 1994

In Brief: NCAB To Hear Report On Controversial Special Virus Cancer Program March 19; Centers, Bladder Project Also On Agenda

March 8, 1974

ACS Encourages Research Proposals Psychosocial Aspects Of Cancer

March 26, 1982

NIH Carcinogen Guidelines Offered

April 24, 1981